Inventor · disambiguated record
Brian Alan Lanman
Also filed as: LANMAN BRIAN · LANMAN BRIAN A · LANMAN BRIAN ALAN
31 granted patents·26 pending applications·461 citations·filing 2006–2025
97Inventor score
Top patents by PatentIndex Score
57 records- 0198US11993597B2Inhibitors of KRAS G12C and methods of using the sameAMGEN INC·Filed 2022·Granted May 28, 2024·8 cites·50 claims
- 0298US11905281B2KRAS G12C inhibitors and methods of using the sameAMGEN INC·Filed 2020·Granted Feb 20, 2024·13 cites·16 claims
- 0398US11766436B2KRAS G12C inhibitors and methods of using the sameAMGEN INC·Filed 2021·Granted Sep 26, 2023·11 cites·19 claims
- 0498US11306087B2Inhibitors of KRAS G12C and methods of using the sameAMGEN INC·Filed 2020·Granted Apr 19, 2022·16 cites·55 claims
- 0598US11090304B2KRAS G12C inhibitors and methods of using the sameAMGEN INC·Filed 2019·Granted Aug 17, 2021·33 cites·3 claims
- 0698US10640504B2Inhibitors of KRAS G12C and methods of using the sameAMGEN INC·Filed 2018·Granted May 5, 2020·50 cites·71 claims
- 0798US10532042B2KRAS G12C inhibitors and methods of using the sameAMGEN INC·Filed 2017·Granted Jan 14, 2020·49 cites·13 claims
- 0898US10519146B2KRAS G12C inhibitors and methods of using the sameAMGEN INC·Filed 2018·Granted Dec 31, 2019·81 cites·33 claims
- 0997US11285135B2KRAS G12C inhibitors and methods of using the sameAMGEN INC·Filed 2019·Granted Mar 29, 2022·20 cites·16 claims
- 1097US11096939B2KRAS G12C inhibitors and methods of using the sameAMGEN INC·Filed 2019·Granted Aug 24, 2021·24 cites·30 claims
- 1197US11045484B2KRAS G12C inhibitors and methods of using the sameAMGEN INC·Filed 2019·Granted Jun 29, 2021·24 cites·34 claims
- 1297US10988485B2KRAS G12C inhibitors and methods of using the sameAMGEN INC·Filed 2019·Granted Apr 27, 2021·27 cites·51 claims
- 1396US12083121B2Substituted piperazines as KRAS G12C inhibitorsAMGEN INC·Filed 2022·Granted Sep 10, 2024·7 cites·5 claims
- 1496US11285156B2Substituted piperazines as KRAS G12C inhibitorsAMGEN INC·Filed 2019·Granted Mar 29, 2022·16 cites·4 claims
- 1595US11053226B2KRAS G12C inhibitors and methods of using the sameAMGEN INC·Filed 2019·Granted Jul 6, 2021·25 cites·48 claims
- 1693US12440491B2KRAS G12C inhibitors and methods of using the sameAMGEN INC·Filed 2023·Granted Oct 14, 2025·1 cites·4 claims
- 1793US10632128B2Compounds that inhibit Mcl-1 proteinAMGEN INC·Filed 2019·Granted Apr 28, 2020·5 cites·49 claims
- 1890US9090593B2Bicyclic compounds as Pim inhibitorsWANG HUI-LING·Filed 2011·Granted Jul 28, 2015·26 cites·51 claims
- 1988US7919519B2S1P receptor modulating compounds and use thereofEPIX PHARM INC·Filed 2007·Granted Apr 5, 2011·14 cites·8 claims
- 2088US2025381187A1Kras g12c inhibitors and methods of using the sameAMGEN INC·Filed 2025·Application pending·0 cites
- 2185US2025362134A1Kras g12c inhibitors and methods of using the sameAMGEN INC·Filed 2025·Application pending·0 cites
- 2284US11845760B2PRMT5 inhibitorsAMGEN INC·Filed 2021·Granted Dec 19, 2023·1 cites·46 claims
- 2384US2024174660A1Kras g12c inhibitors and methods of using the sameAMGEN INC·Filed 2023·Application pending·0 cites
- 2484US2024287068A1Inhibitors of kras g12c and methods of using the sameAMGEN INC·Filed 2024·Application pending·0 cites
- 2582US2025057817A1Kras g12c inhibitors and methods of using the sameAMGEN INC·Filed 2024·Application pending·0 cites
- 2680US8772480B2Inhibitors of PI3 kinase and/or mTORAMGEN INC·Filed 2012·Granted Jul 8, 2014·5 cites·25 claims
- 2780US2024327461A1Apelin polypeptidesAMGEN INC·Filed 2024·Application pending·0 cites
- 2877US7842685B2S1P1 receptor agonists and use thereofAMGEN INC·Filed 2009·Granted Nov 30, 2010·3 cites·32 claims
- 2976US2025304599A1Macrocyclic compounds and methods of useAMGEN INC·Filed 2024·Application pending·0 cites
- 3074US11807693B2Apelin polypeptidesAMGEN INC·Filed 2021·Granted Nov 7, 2023·0 cites·6 claims
- 3174US2022168280A1Kras g12c inhibitors and methods of using the sameAMGEN INC·Filed 2022·Application pending·0 cites
- 3272US11224601B1Compounds that inhibits MCL-1 proteinAMGEN INC·Filed 2020·Granted Jan 18, 2022·0 cites·15 claims
- 3371US8080542B2S1P receptor modulating compounds and use thereofNEIRA SUSANA C·Filed 2008·Granted Dec 20, 2011·2 cites·8 claims
- 3470US2020055845A1Kras g12c inhibitors and methods of using the sameAMGEN INC·Filed 2019·Application pending·0 cites
- 3569US10821115B2Compounds that inhibit Mcl-1 proteinAMGEN INC·Filed 2020·Granted Nov 3, 2020·0 cites·43 claims
- 3669US2025236631A1Macrocyclic compounds and methods of useAMGEN INC·Filed 2025·Application pending·0 cites
- 3769US2024092794A1Novel prmt5 inhibitorsAMGEN INC·Filed 2023·Application pending·0 cites
- 3863US2019375749A1Kras g12c inhibitors and methods of using the sameAMGEN INC·Filed 2019·Application pending·0 cites
- 3961US2007112008A1Saframycins, analogues and uses thereofMYERS ANDREW G·Filed 2006·Application pending·0 cites
- 4059US10941182B2Apelin polypeptidesAMGEN INC·Filed 2015·Granted Mar 9, 2021·0 cites·26 claims
- 4159US2025163064A1Quinazoline compounds and uses thereof as inhibitors of mutant kras proteinsAMGEN INC·Filed 2023·Application pending·0 cites
- 4258US2025179077A1Quinazoline compounds and uses thereof as inhibitors of mutant kras proteinsAMGEN INC·Filed 2023·Application pending·0 cites
- 4356US2023406860A1Heterocyclic spiro compounds and methods of useAMGEN INC·Filed 2021·Application pending·0 cites
- 4455US2025034167A1Heterocyclic compounds and methods of useAMGEN INC·Filed 2022·Application pending·0 cites
- 4555US2024059703A1Heterocyclic spiro compounds and methods of useAMGEN INC·Filed 2021·Application pending·0 cites
- 4655US2025122222A1Heterocyclic compounds and methods of useAMGEN INC·Filed 2022·Application pending·0 cites
- 4754US2025059179A1Heterocyclic Compounds and Methods of UseAMGEN INC·Filed 2022·Application pending·0 cites
- 4854US2024417412A1Heterocyclic compounds and methods of useAMGEN INC·Filed 2022·Application pending·0 cites
- 4954US2025059205A1Heterocyclic Compounds and Methods of UseAMGEN INC·Filed 2022·Application pending·0 cites
- 5052US2023159510A1Novel prmt5 inhibitorsAMGEN INC·Filed 2021·Application pending·0 cites
Showing the top 50 of 57 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Brian Alan Lanman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →